Filing Details
- Accession Number:
- 0001161697-22-000469
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-16 17:01:04
- Reporting Period:
- 2022-09-15
- Accepted Time:
- 2022-09-16 17:01:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1369568 | Catalyst Pharmaceuticals Inc. | CPRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1872422 | Preethi Sundaram | 355 Alhambra Circle Suite 801 Coral Gables FL 33134 | Chief Strategy Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2022-09-15 | 18,214 | $5.49 | 18,214 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2022-09-15 | 18,214 | $14.49 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to purchase common stock | Acquisiton | 2022-09-15 | 18,214 | $0.00 | 18,214 | $5.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 399,286 | 2022-07-06 | 2028-07-06 | No | 4 | M | Direct |
Footnotes
- Shares were sold for personal reasons and not as a result of any disagreement with the Registrant. Dr. Sundaram remains an officer of the Company.
Billionaire Hedge Funds
